Novartis AG

Once-daily dry powder inhaler provides fixed doses of two bronchodilators.

New once-daily inhaler provides fixed-dose combination of two bronchodilators.

A review of launches, new indications, Health Canada advisories and new dosage guidelines

Awaiting National Advisory Committee on Immunization recommendations on vaccine’s optimal use.

A review of launches, new indications, Health Canada advisories and discontinued products.

Reprogrammed cells fight leukemia and lymphoma

OTTAWA | A multi-site North American study led by the Children's Hospital of Eastern Ontario (CHEO) Research Institute has confirmed the validity and reliability of a quality of life measurement tool for children and adults with thalassemia major.

TORONTO | Novari Health has signed a licence agreement with software company Orion Health to incorporate Orion’s Rhapsody Integration Engine into Novari’s Access to Care solution.